Completed PHASE2 INTERVENTIONAL 1-arm NCT02150213

Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492

A Multicenter Medical Safety Follow-up Study for Patients With Partial Onset Seizures Who Received More Than 28 Days of Total Exposure to BGG492 in Studies CBGG492A2207 and/or CBGG492A2212

Sponsor: Novartis Pharmaceuticals

Conditions Adrenocortical Adenoma Endometrial Stromal Sarcomas

Interventions BGG492 Biopsy Dexamethasone Supression Test MRI, CT or ultrasound was permitted if MRI was contraindicated Sonogram

Updated 7 times since 2017 Last updated: Oct 24, 2016 Started: Aug 31, 2014 Primary completion: Sep 30, 2015 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02150213, this PHASE2 trial focuses on Adrenocortical Adenoma and Endometrial Stromal Sarcomas and remains completed. Sponsored by Novartis Pharmaceuticals, it has been updated 7 times since 2014, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Novartis Pharmaceuticals

Data source: Novartis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Baltimore, United States , Banská Bystrica, Slovakia , Bernau, Germany , Bielefeld, Germany , Bonn, Germany , Budapest, Hungary , Dallas, United States , Florence, Italy , Hlohovec, Slovakia , Hoffman, United States and 8 more locations